Arthritis, Rheumatoid

"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Descriptor ID	D001172
MeSH Number(s)	C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
Concept/Terms	Arthritis, Rheumatoid Arthritis, Rheumatoid Rheumatoid Arthritis

Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".

Diseases [C]
Musculoskeletal Diseases [C05]
Joint Diseases [C05.550]
Arthritis [C05.550.114]
Arthritis, Rheumatoid [C05.550.114.154]
Rheumatic Diseases [C05.799]
Arthritis, Rheumatoid [C05.799.114]
Skin and Connective Tissue Diseases [C17]
Connective Tissue Diseases [C17.300]
Rheumatic Diseases [C17.300.775]
Arthritis, Rheumatoid [C17.300.775.099]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Arthritis, Rheumatoid [C20.111.199]

Below are MeSH descriptors whose meaning is related to "Arthritis, Rheumatoid".

Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.

Bar chart showing 247 publications over 29 distinct years, with a maximum of 21 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	3	0	3
1996	2	1	3
1998	2	0	2
1999	0	2	2
2000	1	0	1
2001	0	2	2
2002	2	2	4
2004	1	0	1
2005	2	1	3
2006	2	3	5
2007	5	1	6
2008	10	1	11
2009	7	1	8
2010	14	3	17
2011	5	3	8
2012	11	0	11
2013	16	3	19
2014	12	1	13
2015	20	1	21
2016	16	3	19
2017	13	0	13
2018	12	0	12
2019	18	0	18
2020	6	1	7
2021	6	1	7
2022	8	0	8
2023	11	0	11
2024	10	0	10
2025	1	1	2

Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.

Winthrop KL, Bathon J, Kerschbaumer A, Isaacs JD, Mease P, Gottenberg JE, Crow MK, Kay J, Crofford L, Baraliakos X, Bykerk V, Siebert S, Kloppenburg M, Aletaha D, McInnes IB, Huizinga T, Voll R, Gravallese EM, Breedveld FC, van Vollenhoven R, Smolen JS. Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024. Ann Rheum Dis. 2025 Jun; 84(6):927-936.

View in: PubMed
Fukui S, Winkelmayer WC, Tedeschi SK, Marrugo J, Guan H, Harrold L, Litman HJ, Shinozaki T, Solomon DH. Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb; 84(2):201-209.

View in: PubMed
Harrold LR, Bingham CO, Pope JE, O'Brien J, Moore PC, Roberts-Toler C, Yu M, Sweet LL, Shelbaya A, Masri KR. Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry. Clin Rheumatol. 2025 Feb; 44(2):635-648.

View in: PubMed
Baker JF, Reed G, Mikuls TR, Thiele GM, Pappas DA, Charles-Schoeman C, Guma M, Harrold LR, Curtis JR, Kremer JM. Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis. Arthritis Rheumatol. 2025 Mar; 77(3):263-271.

View in: PubMed
Spandorfer R, Kane K, Pappas DA, Kremer J, Reed G, Curtis JR, Navarro-Mill?n I. New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry. Semin Arthritis Rheum. 2025 02; 70:152559.

View in: PubMed
Huang YC, Lee NY, Weng MY. Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor. J Microbiol Immunol Infect. 2025 Feb; 58(1):112-119.

View in: PubMed
Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, Giles JT, Kremer JM. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Semin Arthritis Rheum. 2024 10; 68:152504.

View in: PubMed
Kay J, Nikolov NP, Weisman MH. American College of Rheumatology and Food and Drug Administration Summit: Summary of the Meeting, May 17-18, 2022. Arthritis Rheumatol. 2024 Sep; 76(9):1323-1333.

View in: PubMed
Winthrop KL, Mease P, Kerschbaumer A, Voll RE, Breedveld FC, Smolen JS, Gottenberg JE, Baraliakos X, Kiener HP, Aletaha D, Isaacs JD, Buch MH, Crow MK, Kay J, Crofford L, van Vollenhoven RF, Ospelt C, Siebert S, Kloppenburg M, McInnes IB, Huizinga TW, Gravallese EM. Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Ann Rheum Dis. 2024 Mar 12; 83(4):409-416.

View in: PubMed
Aripova N, Kremer JM, Pappas DA, Reed G, England BR, Robinson BH, Curtis JR, Thiele GM, Mikuls TR. Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics. Rheumatology (Oxford). 2024 02 01; 63(2):542-550.

View in: PubMed

People

Explore

Similar Concepts

Top Journals